HomeCompareHCCC vs JNJ

HCCC vs JNJ: Dividend Comparison 2026

HCCC yields 15.70% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HCCC wins by $35.9K in total portfolio value
10 years
HCCC
HCCC
● Live price
15.70%
Share price
$12.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55.9K
Annual income
$4,130.13
Full HCCC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HCCC vs JNJ

📍 HCCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHCCCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HCCC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HCCC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HCCC
Annual income on $10K today (after 15% tax)
$1,334.38/yr
After 10yr DRIP, annual income (after tax)
$3,510.61/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HCCC beats the other by $2,807.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HCCC + JNJ for your $10,000?

HCCC: 50%JNJ: 50%
100% JNJ50/50100% HCCC
Portfolio after 10yr
$38.0K
Annual income
$2,478.95/yr
Blended yield
6.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HCCC
Analyst Ratings
1
Buy
Consensus: Buy
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HCCC buys
0
JNJ buys
0
No recent congressional trades found for HCCC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHCCCJNJ
Forward yield15.70%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$55.9K$20.0K
Annual income after 10y$4,130.13$827.78
Total dividends collected$27.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: HCCC vs JNJ ($10,000, DRIP)

YearHCCC PortfolioHCCC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,270$1,569.86$10,676$355.77+$1.6KHCCC
2$14,929$1,800.18$11,407$389.39+$3.5KHCCC
3$18,021$2,047.02$12,198$426.53+$5.8KHCCC
4$21,592$2,309.34$13,056$467.62+$8.5KHCCC
5$25,689$2,585.91$13,987$513.12+$11.7KHCCC
6$30,363$2,875.35$14,998$563.56+$15.4KHCCC
7$35,664$3,176.13$16,098$619.52+$19.6KHCCC
8$41,647$3,486.64$17,295$681.69+$24.4KHCCC
9$48,368$3,805.20$18,599$750.82+$29.8KHCCC
10$55,884$4,130.13$20,022$827.78+$35.9KHCCC

HCCC vs JNJ: Complete Analysis 2026

HCCCStock

As of March 7, 2022, Healthcare Capital Corp. was acquired by Alpha Tau Medical Ltd., in a reverse merger transaction. Healthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.

Full HCCC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HCCC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HCCC vs SCHDHCCC vs JEPIHCCC vs OHCCC vs KOHCCC vs MAINHCCC vs ABBVHCCC vs MRKHCCC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.